Nonpartisan civic infrastructure
AllCiv·Legis1
·

S. 1384

BillFederalSenateIn Committee
A bill to reform prescription drug pricing and reduce out-of-pocket costs by ensuring consumers benefit from negotiated rebates.
About This Bill
Committee
Latest Action · May 9, 2019
Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
Congress
116th (2019–2021)
Introduced
May 9, 2019
Cosponsors (2)
0D 2R
View PDF ↗

Summary

Highlight any text to annotate
Prescription Drug Rebate Reform Act of 2019 This bill requires private health insurance plans to set any coinsurance rate for a covered prescription drug based on the net price of the drug (the price after accounting for rebates and discounts provided by the drug manufacturer) and not the list price (the initial wholesale price set by the drug manufacturer). This requirement applies when a plan holder has an unmet deductible or other coinsurance obligation for prescription drug benefits under the plan. The bill does not prohibit a plan from requiring a copayment provided that such copayment is not based on the cost of the drug.

Take Action

Your position
Add a comment
to comment on this bill.
Annotate the text
Highlight any passage on the Summary or Full Text tab to attach a note. Annotations appear on the Annotations tab.